Deltex Medical Group plc
OTC: DTXMF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Natalie Emilia Wettler
- Employees
- 24
- Headquarters
- Chichester, United Kingdom
- IPO year
- 2009
- Market cap
- $180.6M
- Website
- https://www.deltexmedical.com
Loading DTXMF…
Loading profile data…Frequently asked questions about DTXMF
What does Deltex Medical Group plc (DTXMF) do?
Deltex Medical Group plc, with its global presence encompassing the United Kingdom, the United States, Spain, and Canada, is dedicated to the development, marketing, and distribution of its TrueVue brand of esophageal Doppler hemodynamic monitoring systems. The company's innovative product lineup features: Esophageal Doppler Probes: These probes...
Where does DTXMF trade?
Deltex Medical Group plc (DTXMF) trades on the Other OTC.
What sector is DTXMF in?
Deltex Medical Group plc (DTXMF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Deltex Medical Group plc?
Natalie Emilia Wettler is the chief executive officer of Deltex Medical Group plc (DTXMF).
Where is Deltex Medical Group plc headquartered?
Deltex Medical Group plc is headquartered in United Kingdom.
Does DTXMF pay a dividend?
Deltex Medical Group plc (DTXMF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DTXMF go public?
Deltex Medical Group plc (DTXMF) completed its initial public offering in 2009.